You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
启迪古汉(000590.SZ)拟斥3000万元设立全资子公司 扩大化学原料药生产规模及拓展医药中间体项目建设
格隆汇 08-28 16:19

格隆汇8月28日丨启迪古汉(000590.SZ)公布,公司拟出资人民币3000万元,在湖南省衡东县注册成立“湖南启迪古汉医药科技有限公司”(暂定名,最终以工商行政管理部门登记为准。“医药科技”),出资完成后,医药科技将成为公司的全资子公司。

湖南启迪古汉医药科技有限公司(暂定名)经营范围:化学原料和化学制品的生产及销售;化学药品原料药、化学药品制剂、兽用药品、抗生素原料药、抗生素制剂、生化药品、饮料、饮用水、卫生材料及医药用品的生产及销售;医药科技领域内的技术开发、技术转让、技术咨询、技术服务;货物进出口;技术进出口;在药品生产许可证范围内进行来料加工和“三来一补”业务。(依法须经批准的项目,经相关部门批准后方可开展经营活动)

此次投资设立新公司是为了扩大化学原料药生产规模及拓展医药中间体项目建设,有利于调整公司化学药产品结构,优化公司的医药产业布局,符合公司长远发展战略,对提升公司的盈利能力和综合竞争实力将起到积极作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account